FDA Drug Application (202015) for YAELA by NOVAST LABS LTD

Back to FDA Applications sponsored by NOVAST LABS LTD

Application Number202015
Product Number001
FormTABLET;ORAL-28
Dosage3MG;0.03MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameYAELA
Active IngredientDROSPIRENONE; ETHINYL ESTRADIOL



Back to FDA Applications sponsored by NOVAST LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.